Navigating the evolving world of biomarker testing in early-stage breast cancer can be overwhelming—for both healthcare providers and patients.
Biomarker tests, including the Prosigna Breast Cancer Assay, are key in making informed treatment decisions. They can help determine whether to pursue chemotherapy and what a patient’s risk for recurrence is. This information can lead to some stressful conversations. While some patients may be unaware of these tests and their benefits, others arrive at appointments ready with research and questions.
Living Beyond Breast Cancer and Seth Wander, M.D., Ph.D., offer a free, on-demand webinar designed for healthcare providers to gain a deeper understanding of biomarker testing and how to confidently discuss these options with your patients.
Speakers
Seth Wander, M.D., Ph.D.
Massachusetts General Hospital
Tags
On Demand
Prosigna Breast